Advertisement
Skip to Content

Dentsply Sirona Inc XRAY Stock Quote

| Rating as of

NASDAQ: XRAY

Last close prices updated as of Feb 06, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 38.09
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Investment Style Mid Value
  • Day Range 37.93  –  38.69
  • Year Range 26.48  –  58.70
  • Market Cap 8.1860 Bil
  • Volume / Avg 1.4 Mil /  2.2 Mil
  • Price / Sales 2.03
  • Price / Book 2.27
  • Forward Div Yield 1.31%
  • Trailing Div Yield 1.31%

Morningstar‘s Stock Analysis XRAY

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics XRAY

Company Profile XRAY

Business Description

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters; and Consumables segment is responsible for the design, manufacture, sales, and distribution of dental consumable products which include categories of preventive, restorative, endodontic, and dental laboratory application. The majority of its products are sold through dental distributors, and over half of its sales are outside the U.S.

Contact
13320 Ballantyne Corporate Place
Charlotte, NC, 28277-3607
Industry Medical Instruments & Supplies
Employees 15,000

Related Articles XRAY

FAQs for Dentsply Sirona Inc Stock

Yes. XRAY has a forward dividend yield of 1.31%. See XRAY’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

XRAY’s market cap is 8.19 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

XRAY’s stock style is Mid Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

XRAY’s price/sales is 2.03.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

XRAY’s price/forward earnings is 21.14.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

XRAY’s price/book is 2.27.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See XRAY’s valuation ratios compared to the Market Index.

XRAY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare XRAY’s historical performance against its industry peers and the overall market.